New controlling shareholder of Redpont Biotech to build nicotinamide and NMN project

Summary: EIA report of Haiwen Biotech's project of 600 t/a cosmetic-grade nicotinamide and 50 t/a NMN was publicised; the project was proposed by Haiwen Biotech after it acquired 100% equity of Redpont Biotech. On 7 May, environmental impact assessme...

Vitamins China E-News 202205

www.cnchemicals.com